Human Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) Protein

Este producto es parte de BCAR scaffold protein, Cas family member
Human Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) Protein
221€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Human Breast Cancer Anti-Estrogen Resistance 1 (BCAR1) Protein
Category
Proteins and Peptides
Provider
Abbexa
Reference
abx166777
Tested Applications
WB, SDS-PAGE

Description

Human Breast Cancer Anti-Estrogen Resistance 1 Protein is a recombinant Human protein expressed in E. coli.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Proteins and Peptides
Immunogen Target
Breast Cancer Anti-Estrogen Resistance 1 (BCAR1)
Host
E. coli
Assay Type
Activity: Not tested
Sequence Fragment: Met1-Leu240
Tag: N-terminal His tag
Origin
Human
Conjugation
Unconjugated
Observed MW
Calculated MW: 29.7 kDa
Expression
Recombinant
Purity
> 95%
Size 1
10 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
500 µg
Form
Lyophilized
Tested Applications
WB, SDS-PAGE
Buffer
Prior to lyophilization: PBS, pH 7.4, containing 0.01% Sarcosyl, 1 mM DTT, 5% Trehalose and Proclin-300.
Availability
Shipped within 5-7 working days.
Storage
Store lyophilized form at 2-8°C for up to 1 month. For longer periods, store lyophilized or liquid at -80°C. Avoid repeated freeze–thaw cycles.
Dry Ice
No
Alias
BCAR1, CAS, CAS1, CASS1, CRKAS, P130Cas, Cas family scaffolding protein, Cas family scaffold protein, BCAR1 scaffold protein, Cas family member
Background
Protein BCAR1
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
Concentration: Prior to lyophilization: 200 µg/ml

Background

BCAR1, also known as the Breast Cancer Anti-Estrogen Resistance 1 protein, is an important protein involved in the development of resistance to anti-estrogen therapies, such as tamoxifen, used in the treatment of estrogen receptor-positive breast cancer. BCAR1 plays a crucial role in cell signaling pathways that regulate cell survival, proliferation, and resistance to apoptosis. It is often upregulated in breast cancer cells that become resistant to estrogen receptor-targeted therapies. The protein interacts with several other signaling molecules involved in the regulation of cell motility and survival, contributing to the metastatic potential of breast cancer cells. Understanding BCAR1’s role in therapy resistance has significant implications for developing alternative therapeutic strategies for patients with estrogen receptor-positive breast cancer who develop resistance to current treatments.

Productos relacionados

abx010317

Breast Cancer Anti-Estrogen Resistance Protein 1 (BCAR1) Antibody

Breast Cancer Anti-Estrogen Resistance Protein 1 (BCAR1) Antibody is a Rabbit Polyclonal antibody for the detection of B…

Ver producto
abx012424

Breast Cancer Anti-Estrogen Resistance Protein 1 Phospho-Tyr410 (BCAR1 pY410) Antibody

Rabbit polyclonal antibody against p130 Cas protein. Immunogen region is Internal. Specificity is as follows for the rea…

Ver producto
abx034763

Breast Cancer Anti-Estrogen Resistance Protein 1 (Bcar1) Antibody

Docking protein which plays a central coordinating role for tyrosine kinase-based signaling related to cell adhesion. Im…

Ver producto